Differential Expression of Salivary Biomarkers in Smokeless Tobacco Users: A Cross‐Sectional Study
Oral Diseases · 2026-10 · 32 (10) · 3189-3196
DOI: 10.1111/odi.70375 ↗At a glance
Journal article in Oral Diseases, published online on 2026-06-02. Written by Mohammad S Alrashdan and 6 co-authors. Institution: Department of Oral & Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah, UAE. Major MEDLINE topics: Tobacco, Smokeless, Saliva, Salivary Proteins and Peptides. 34 references. Funded by: University of Sharjah.
Abstract (original language)
Objective
The use of smokeless tobacco (SLT) is associated with significant harm to oral health and salivary biomarkers have recently emerged as potential indicators of such harm. This study evaluated levels of key salivary proteins, including inflammatory cytokines and vascular dysfunction biomarkers, among SLT users and examined the influence of usage characteristics on these levels.
Methods
A total of 62 male participants, aged 24–55 years, were equally allocated to either SLT users or controls (non‐users) groups. Expression of salivary interleukin 1β (IL‐1β), tumor necrosis factor alpha (TNF‐α), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), endothelin‐1 (ET1), and transferrin (TF) was evaluated using ELISA. Multiple linear regression assessed effects of mixed SLT use, areca‐nut content, duration and frequency of use on biomarker expression.
Results
SLT users exhibited significantly elevated levels of VEGF, EGF, and ET1 ( p < 0.0001), TF, and IL‐1β ( p < 0.05) compared to controls. Additionally, using more than one type of SLT was significantly associated with higher expression of VEGF and TF.
Conclusions
SLT consumption is associated with significant upregulation of pro‐inflammatory cytokines and biomarkers of endothelial dysfunction, while mixed use of SLT products may further potentiate these effects. These findings highlight the potential pathogenic impact of SLT on oral health.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Oral & Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah, UAE.
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, UAE.
- Oral Medicine and Experimental Pathology, King's College London and WHO Collaborating Centre for Oral Cancer, London, UK.
ORCID profiles: Mohammad S Alrashdan, K G Aghila Rani, Natheer Al-Rawi, Suhail H Al-Amad, Sausan AlKawas, Saman Warnakulasuriya
Funding
- University of Sharjah
Cite
APA
Alrashdan, M. S., Aghila Rani, K. G., Saqan, R., Al-Rawi, N., Al-Amad, S. H., AlKawas, S., & Warnakulasuriya, S. (2026). Differential Expression of Salivary Biomarkers in Smokeless Tobacco Users: A Cross‐Sectional Study. Oral Diseases, 32(10), 3189-3196. https://doi.org/10.1111/odi.70375
Vancouver
Alrashdan MS, Aghila Rani KG, Saqan R, Al-Rawi N, Al-Amad SH, AlKawas S, et al. Differential Expression of Salivary Biomarkers in Smokeless Tobacco Users: A Cross‐Sectional Study. Oral Diseases. 2026;32(10):3189-3196. doi:10.1111/odi.70375
BibTeX
@article{Alrashdan2026,
author = {Alrashdan, Mohammad S and Aghila Rani, K G and Saqan, Roba and Al-Rawi, Natheer and Al-Amad, Suhail H and AlKawas, Sausan and Warnakulasuriya, Saman},
title = {Differential Expression of Salivary Biomarkers in Smokeless Tobacco Users: A Cross‐Sectional Study},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {10},
pages = {3189--3196},
doi = {10.1111/odi.70375}
}
EUVIMED